QMS Medical Allied Services Intrinsic Value
QMS Medical Allied Services (QMSMEDI) median intrinsic value is ₹78.32 from 9 valuation models (range ₹32–₹200), vs current price ₹107.56 — -27.2% downside (Trading Above Calculated Value), margin of safety -37.3%. Read QMS Medical Allied Services dividend policy for the complete payout history and dividend yield track record.
QMSMEDI Valuation Methods Summary — DCF, Graham Number & P/E
QMS Medical Allied Services intrinsic value across 9 models vs current price ₹107.56 — upside/downside and value range per method. For current market price and key ratios, visit QMS Medical Allied Services share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹78.32 | ₹62.66 - ₹93.98 | -27.2% | EPS: ₹3.56, Sector P/E: 22x |
| Book Value Method | asset | ₹118.89 | ₹107.00 - ₹130.78 | +10.5% | Book Value/Share: ₹59.44, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹200.00 | ₹180.00 - ₹220.00 | +85.9% | Revenue/Share: ₹100.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹133.33 | ₹120.00 - ₹146.66 | +24.0% | EBITDA: ₹24.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹150.93 | ₹120.74 - ₹181.12 | +40.3% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹32.27 | ₹29.04 - ₹35.50 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹55.00 | ₹49.50 - ₹60.50 | -48.9% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹53.78 | ₹48.40 - ₹59.16 | -50.0% | ROE: 7.5%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹69.00 | ₹62.10 - ₹75.90 | -35.8% | EPS: ₹3.56, BVPS: ₹59.44 |
QMSMEDI Intrinsic Value vs Market Price — All Valuation Models
QMS Medical Allied Services fair value range ₹32–₹200 vs current market price ₹107.56 across 9 valuation models. Analyse QMSMEDI FII DII holdings to track promoter, FII and institutional holdings.
QMSMEDI Intrinsic Value Analysis — Undervalued or Overvalued?
QMS Medical Allied Services median intrinsic value ₹78.32, current price ₹107.56 — Trading Above Calculated Value by 27.2%, margin of safety -37.3%.
What is the intrinsic value of QMSMEDI?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of QMS Medical Allied Services (QMSMEDI) is ₹78.32 (median value). With the current market price of ₹107.56, this represents a -27.2% variance from our estimated fair value.
The valuation range spans from ₹32.27 to ₹200.00, indicating ₹32.27 - ₹200.00.
Is QMSMEDI undervalued or overvalued?
Based on our multi-method analysis, QMS Medical Allied Services (QMSMEDI) appears to be trading above calculated value by approximately 27.2%.
QMSMEDI Financial Health — Key Ratios vs Industry Benchmarks
QMS Medical Allied Services financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 7.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.95x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
QMSMEDI Cash Flow Quality — Operating & Free Cash Flow
QMS Medical Allied Services operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹20 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |